From API to Patient: Achieving Supply Chain Visibility & Control

Clinical trials depend on complex global supply networks, yet most clinical supply chains operate with fragmented visibility across planning, manufacturing, and distribution. When supply issues arise such as manufacturing delays or quality events, disconnected systems turn manageable situations into resource-intensive crises that risk trial timelines and patient safety.

This white paper examines how integrated technology solutions eliminate supply chain blind spots by connecting patient-level dispensing data with upstream manufacturing operations. The analysis reveals how end-to-end visibility transforms supply chain management from reactive crisis response to proactive risk mitigation, enabling sponsors to instantly assess quality impacts, execute comprehensive lot recalls, and optimize inventory across multiple studies.

Key topics include:

• RTSM platform foundations for real-time visibility
• Strategies for integrating manufacturing with patient dispensing
• Advanced complexity management for cold chain and expiry requirements
• The regulatory imperative for comprehensive transparency under increasing FDA scrutiny

Discover how leading pharmaceutical companies are achieving unprecedented supply chain visibility and control, transforming operational excellence into a patient safety imperative.